I-MAB ADR (NASDAQ:IMAB)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IMAB

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IMAB

  • Market Cap$6.002bn
  • SymbolNASDAQ:IMAB
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS44975P1030

Company Profile

I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company's drug candidates are TJ202 for Multiple myeloma/Autoimmune diseases, TJ101 for Pediatric growth hormone deficiency, TJ301 for Ulcerative colitis/Autoimmune disease, Enoblituzumab for Head & neck cancer/Oncology, and TJ107 for Oncology-related lymphopenia.

Latest IMAB news

Currently there for this company. Visit our news hub for other news .